Looking at the pipeline for Fibrologics shows that the bars move very, very slowly.  It looks like the Multiple Sclerosis bar is the furthest along and after almost three years (the site has said "over two years" for quite a while now), the MS bar has remained at the border of phase 1 and phase 2. I think this is the nature of this type of medical research company, with profitability--beyond Phase 3--taking quite a while. I'm going to be positive and believe that LBSR's progress bar will move much, much faster than the FBLG pipeline bars. Anyway, I'm hoping that Pete has 2 or 3 more $70,000 or more loans to LBSR in him that he can do with minimal use of Diagonal, and his loan money getting us closer to an outside funding source.